China Resources Pharmaceutical Group Ltd
CR Pharma's GHG Emissions Data Preview
In 2024, CR Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, CR Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Verified Sources Behind CR Pharma’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore CR Pharma’s data sources below and access millions more through our Disclosure Search.
Insights into CR Pharma's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of CR Pharma amounted to 722,459.8 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of CR Pharma decreased by 0.44%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
CR Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are CR Pharma's Scope 1 emissions?
In 2024, the total Scope 1 emissions of CR Pharma were 175,023.13 metric tons of CO₂ equivalent (tCO₂e). a
Has CR Pharma reduced its Scope 1 emissions over time?
Since 2021, CR Pharma's Scope 1 emissions have increased by 43.74%, reflecting a rising long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2023), CR Pharma's Scope 1 emissions increased by 2.63%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
What are CR Pharma's Scope 2 emissions?
In 2024, CR Pharma reported Scope 2 greenhouse gas (GHG) emissions of 547,436.67 tCO₂e without specifying the calculation method. a
Has CR Pharma reduced its Scope 2 emissions over time?
Since 2021, CR Pharma's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have remained relatively stable, indicating that CR Pharma 's emissions have plateaued with no significant change in its energy consumption footprint. a b
Compared to the previous year (2023), CR Pharma's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that CR Pharma 's emissions have plateaued with no significant change in its energy consumption footprint. a
What methodology does CR Pharma use for Scope 2 reporting?
In 2024, CR Pharma reported its Scope 2 emissions using an unspecified methodology. a
CR Pharma's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into CR Pharma’s GHG Emissions Intensity Compared to Industry Peers
In 2024, CR Pharma reported Scope 1 greenhouse gas (GHG) emissions of 175,023.13 tCO₂e and total revenues of USD 38,435 millions. This translates into an emissions intensity of 4.55 tCO₂e per millions USD. a
CR Pharma's Scope 1 Emissions Intensity Compared to Peers
How does CR Pharma's GHG emissions intensity compare to its peers?
In 2024, CR Pharma reported a Scope 1 emissions intensity of 4.55 tCO₂e per millions USD. Compared to the peer group median of 9.96 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
Where does CR Pharma rank on GHG emissions intensity within its industry?
In 2024, CR Pharma ranked 7 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
CR Pharma is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a